(Q48328647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

meta-analysis

0 references

title

Apolipoprotein E in schizophrenia: a French association study and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Andrei Szöke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Marion Leboyer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

Franck Schürhoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Jean-Yves Loze

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Céline Goldberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Valérie Quignon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jean Tignol

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Frédéric Rouillon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jean-Louis Laplanche

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

119B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

18-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Free radical pathology and antioxidant defense in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Alzheimer-type neuropathology in elderly schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

No implication of apolipoprotein E polymorphism in Italian schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E ɛ4 and clinical phenotype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E genotype in Spanish schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E alleles in childhood-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E type ϵ4 allele frequency is increased in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E genotype and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E genotype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon4 allele and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon2 allele and early onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon4 and tardive dyskinesia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E genotype and schizophrenia: further negative evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20007

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.20007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707932%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference